Lonza signs agreement with Index Ventures for development and manufacture of biologics

07:04 AM | January 9, 2014 | Deepti Ramesh

Lonza and Index Ventures, a leading venture capital investment firm, have signed an exclusive five-year agreement for process development and cGMP production for all biological products in the...